HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Novavax (NVAX) Investors with Significant Losses to Contact Firm’s Attorneys Now, Firm Investigati

[ASFN Admin]

SAN FRANCISCO, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Novavax, Inc. (NASDAQ: NVAX) investors with significant losses to submit your losses now. Visit: www.hbsslaw.com/investor-fraud/NVAXContact An Attorney Now: [email protected] 844-916-0895 Novavax, Inc. (NVAX) Investigation: The U.S. government invested approximately $1.6 billion in Novavax in 2020 in the hopes it would offer a safe and effective vaccine to help protect against COVID-19. The investigation focuses on Novavax’s and

Continue reading...